Differing opinions about AMFm ‘unlikely to be resolved’ after Global Fund decision on program’s future

In her “Global Health Blog,” Guardian health editor Sarah Boseley examines the Affordable Medicines Facility-malaria (AMFm), “which aims to enable countries to increase the provision of inexpensive artemisinin combination therapies (ACTs) through not only the public sector but also the private sector and [non-governmental organizations (NGOs)].” Following pilot projects in seven African countries and an independent evaluation by the London School of Hygiene and Tropical Medicine, the Global Fund to Fight AIDS, Tuberculosis and Malaria, which hosts AMFm, is set to decide the future of the scheme at a board meeting in November. She notes Oxfam recently released a report criticizing the mechanism, saying the evaluation was flawed because it looked at the number of ACTs sold and not lives saved.

Related News:

• Teen Dating Violence Affects Adult Health
• HIV Rates Reaching Epidemic Levels In Greece
• Reactions to each day stressors predict future health
• Diabetes During Pregnancy
• Electronic Medical Records Reduce Negative Outcomes and Related Costs After Patient Safety Events Occur
• Patients won’t ask doctors to come clean on hand-washing
• Device theft poses greatest risk for health data breaches
• Device theft poses greatest risk for health data breaches
• Dual-eligibles market creates opportunities for doctor practices
• Dual-eligibles market creates opportunities for doctor practices

Details :
Submited at Friday, October 26th, 2012 at 8:15 am on Uncategorized by madison
Comment RSS 2.0 - leave a comment - trackback